This procedure outlines the responsibilities of the OIRB and the IRB for documentation of convened IRB proceedings.

This procedure outlines the responsibilities of the investigator, OIRB and IRB for approving a waiver or alteration of the consent process and the waiver of consent documentation.

Clinical investigations involving human subjects and drugs, biologics, devices or test articles are subject to review. In order to comply with federal regulations, the IRB will determine what types of applications and exemptions (when applicable) are required for the study. This document describes various types of studies and instructions for submission and compliance.

This policy describes the process by which the IRB determines if risks are minimized for participants in a proposed project. Review process and relevant definitions are included in the document.

This policy outlines UAB's approach to determining whether use of commercially available cell lines is defined as human subjects research.

This policy details the process for reviewing and handling financial (or other) conflicts of interest surrounding the investigator of a proposed project.

This policy describes documentation requirements for the OIRB (Office of the IRB).

This guidebook contains information on the IRB and its relevance to UAB Investigators. Specific instructions on training, the review process and approvals are included in the guidebook.

This policy details the additional safeguards that must be used when conducting research that involves children.

This policy defines the circumstances that constitute an IRB member and consultant conflict of interest. Immediate family members, dependents, and anyone else who has a personal, professional, or financial tie with an IRB member or consultant may not be reviewed by that member or consultant.